| Literature DB >> 24147042 |
Bright Varghese1, Philip Supply, Mohammed Shoukri, Caroline Allix-Beguec, Ziad Memish, Naila Abuljadayel, Raafat Al-Hakeem, Fahad AlRabiah, Sahal Al-Hajoj.
Abstract
BACKGROUND: Eastern province of Saudi Arabia is an industrial zone with large immigrant population and high level of tuberculosis case notification among immigrants. The impact of immigration and current trends of tuberculosis transmission among immigrants and autochthonous population in the region had not been investigated so far using molecular tools.Entities:
Mesh:
Year: 2013 PMID: 24147042 PMCID: PMC3798324 DOI: 10.1371/journal.pone.0077635
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Geographical origin of the 524 study subjects.
Figure shows the number of isolates enrolled into the study with nationality of the patients in the left side and number of cases with percentage of overall distribution and geographical origin in the right side.
Demographical summary of 524 cases enrolled into the study.
| Parameters | Patient Geographical Origin (n/%) | ||||
|---|---|---|---|---|---|
| Saudi (n=210) | South Asia (n=185) | South East Asia (n=96) | Africa (n=16) | West Asia (n=17) | |
|
| |||||
|
| 4 (1.9) | ||||
|
| 88(41.9) | 83 (44.9 ) | 49 (51) | 11 (68.7) | 13 (76.4) |
|
| 64 (30.5) | 72 (41.6) | 30 (33.3) | 2 (12.5) | 2 (11.8) |
|
| 36 (17.1) | 25 (10.8) | 17 (15.6) | 3 (18.7) | 2 (11.8) |
|
| 18 (8.6) | 5 (2.7 ) | |||
|
| |||||
|
| 138 (65.7) | 169 (91.4) | 40 (41.7) | 5 (31.2) | 14 (77.8) |
|
| 72 (34.3) | 16 (8.6) | 56(58.3) | 11(68.8) | 3 (22.2) |
|
| 1.9 | 10.6 | 0.71 | 0.66 | 3.5 |
|
| |||||
|
| 141(67.2) | 149 (80.5) | 70 (72.9) | 14 (87.5) | 15 (88.2) |
|
| 101 | 139 | 33 | 5 | 13 |
|
| 40 | 10 | 37 | 9 | 2 |
|
| 69 (32.8) | 36 (19.5) | 26 (27.1) | 2 (12.5) | 2 (11.8) |
|
| 32 | 30 | 7 | 1 | |
|
| 37 | 6 | 19 | 2 | 1 |
|
| 2.0 | 4.1 | 2.7 | 7 | 7.5 |
Male/Female ratio
Pulmonary/extra-pulmonary ratio
Diversity and distribution of lineages according to the geographical origin of patients.
| Lineages[ | Study Groups (Case/Percentage) | Geographical origin of immigrants | |||||
|---|---|---|---|---|---|---|---|
| Total (N=524) | Saudi (N=210) | Non-Saudi (N=314) | South Asia | South East Asia | Africa | West Asia | |
| Delhi/CAS | 154 (29.4) | 70 (33.3) | 84 (26.7) | 71 | 10 | 2 | 1 |
| EAI | 125 (23.8) | 28 (13.3) | 97 (30.9) | 52 | 39 | 4 | 2 |
| Ghana | 70 (13.3) | 30 (14.3) | 40 (12.7) | 19 | 7 | 3 | 11 |
| Haarlem | 45 (8.6) | 24 (11.4) | 21 (6.7) | 9 | 12 | ||
| Beijing | 38 (7.2) | 11 (5.2) | 27(8.6) | 12 | 14 | 1 | |
| LAM | 26 (5.0) | 15 (7.1) | 11 (3.5) | 4 | 5 | 1 | 1 |
| S | 17 (3.2) | 9 (4.3) | 8 (2.6) | 5 | 3 | ||
| Uganda-I | 12 (2.3) | 9 (4.3) | 3 (1.0) | 2 | 1 | ||
| URAL | 11 (2.1) | 6 (2.8) | 5 (1.6) | 3 | 1 | 1 | |
| New-I | 10 (1.9) | 2 (0.9) | 8 (2.5) | 5 | 3 | ||
| X | 7 (1.3) | 1 (0.5) | 6 (1.9) | 3 | 1 | 2 | |
| Cameroon | 4 (0.8) | 4 (1.3) | 2 | 2 | |||
| TUR | 3 (0.6) | 3 (1.4) | |||||
| Unknown | 2 (0.4) | 2 (0.9) | |||||
Lineages assigned based on the MIRU-VNTR plus online database, number of lineages among the study group Non-Saudi showed as numbers.
Pattern of drug resistance in the study.
| Parameters | Drug resistance pattern[ | Total (N/%) | ||
|---|---|---|---|---|
| Mono drug | Polydrug | MDRTB | ||
|
| ||||
| Saudi | 23 | 5 | 9 | 37(17.6) |
| Non Saudi | 51 | 14 | 4 | 69(21.9) |
| Total | 74 (14.1) | 19 (3.6) | 13 (2.5) | 106 (20.2) |
| P value | 0.115 | 0.313 | 0.060 | |
|
| ||||
| Indo-Oceanic | 15 | 1 | 3 | 19(16.7) |
| East African Indian | 18 | 7 | - | 25 (21.9) |
| East Asian | 5 | - | 4 | 9 (7.9) |
| Euro-American | 36 | 11 | 6 | 53 (46.5) |
| P value | 0.509 | 0.141 | 0.005 | |
Drugs used for susceptibility testing, Streptomycin, Isoniazid, Rifampicin and Ethambutol, poly-resistance- resistance to more than one drug, MDRTB- resistance to both INH and RIF
Lineages found in this study are defined as, Indo-Oceanic lineage- EAI; East African Indian-CAS (Delhi/CAS); East Asian-Beijing; Euro-American–Haarlem, Ghana, LAM, S, Uganda-I and Cameroon.
Nomenclature of strain clusters and their distribution among patients of different nationalities.
| MIRU Lineage[ | SIT[ | Clades | Clustered isolates | Immigrants (N/%) | Nationalities |
|---|---|---|---|---|---|
| EAI | 1501 | EAI-2 Manila | 5 | 3(60) | Philippines, Indonesia, SA[ |
| EAI | 1501 | EAI-2 Manila | 8 | 8(100) | Philippines, Indonesia, India |
| EAI | 109 | EAI-8 MDG | 2 | SA | |
| EAI | 11 | EAI_3 India | 4 | 4(100) | India, Bangladesh |
| EAI | 11 | EAI_3 India | 2 | 2(100) | Sri Lanka |
| EAI | 654 | EAI_3 India | 2 | 2(100) | Bangladesh |
| EAI | 299 | EAI_5 | 2 | 2(100) | Somalia |
| EAI | 19 | EAI_2 Manila | 4 | 2(50) | Philippines, Indonesia, SA |
| EAI | 19 | EAI_2 Manila | 4 | 1(25) | Indonesia, SA |
| EAI | 19 | EAI_2 Manila | 21 | 21(100) | Philippines |
| Haarlem | 47 | H1 | 6 | 2(33.3) | Pakistan, Indonesia, SA |
| Haarlem | 47 | H1 | 5 | 3(60) | Bangladesh, Philippines, SA |
| Haarlem | 47 | H1 | 3 | 1(33.3) | Indonesia, SA |
| Haarlem | 50 | H1 | 3 | SA | |
| Haarlem | 168 | H3 | 2 | 2(100) | Indonesia, Nepal |
| URAL | 35 | H3 | 4 | 3(75) | Indonesia, Philippines, SA |
| Ghana | 53 | T1 | 15 | 9(60) | Yemen, Nigeria, Chad, Cameroon, SA |
| Ghana | 53 | T1 | 8 | 3(50) | Yemen, SA |
| Ghana | 53 | T1 | 6 | 4(66.7) | Yemen, SA |
| Ghana | 53 | T1 | 5 | 3(60) | Yemen, Cameroon, SA |
| LAM | 42 | LAM-9 | 3 | 2(66.7) | Pakistan, SA |
| LAM | 162 | LAM-9 | 8 | 3(37.5) | Indonesia, SA |
| LAM | 162 | LAM-9 | 3 | 1(33.3) | Philippines, SA |
| Beijing | 1 | Beijing | 3 | 1(33.3) | Indonesia, SA |
| Beijing | 255 | Beijing | 6 | 6(100) | Indonesia, China, Thailand |
| Beijing | 1 | Beijing | 4 | 2(50) | Philippines, SA |
| Delhi/CAS | 1401 | CAS1_Delhi | 5 | 5(100) | Bangladesh, Nepal |
| Delhi/CAS | 1401 | CAS1_Delhi | 5 | 5(100) | Bangladesh, India, Pakistan |
| Delhi/CAS | 1401 | CAS1_Delhi | 3 | 1(33.3) | Bangladesh, SA |
| Delhi/CAS | 26 | CAS1_Delhi | 6 | 5(83.3) | Bangladesh, India, SA |
| Delhi/CAS | 26 | CAS1_Delhi | 9 | 6(66.7) | Bangladesh, India, Nepal, Pakistan, SA |
| Delhi/CAS | 26 | CAS1_Delhi | 7 | 7(100) | Bangladesh, India, Myanmar, Nepal |
| Delhi/CAS | 486 | CAS1_Delhi | 4 | 2(50) | Pakistan, SA |
| Delhi/CAS | 357 | CAS1_Delhi | 2 | 1(50) | India, SA |
| Delhi/CAS | 25 | CAS1_Delhi | 2 | 2(100) | Bangladesh |
| Delhi/CAS | 25 | CAS1_Delhi | 9 | 7(77.8) | Bangladesh, India, Nepal, Pakistan, SA |
| Delhi/CAS | 25 | CAS1_Delhi | 3 | 3(100) | Pakistan, Afghanistan |
| Delhi/CAS | 1264 | CAS | 2 | 2(100) | Pakistan |
| Delhi/CAS | 1093 | CAS | 4 | 3(75) | India, Sudan, SA |
| S | 784 | S | 3 | 1(33.3) | Indonesia, SA |
| S | 34 | S | 5 | 2(40) | Philippines, SA |
| TUR | 41 | LAM7-TUR | 3 | SA |
Lineage defined using MIRUVNTR Plus online database
Defined with the help of SITVIT web.
Saudi Arabia
Figure 2Strain cluster distribution among different study groups.
Geographical origin of the patients’ versus number of strain clusters. Figure A shows the geographic region specific clusters found in the study. Figure B shows the different cross-national clustering between the immigrant and autochthonous population. The single cluster between immigrant study groups (SEA+SAS) was not shown in the figure.
Predisposing factors for molecular strain clustering in the province.
| Risk Factors | Total cases | Clustered cases/% (N=210) | P value |
|---|---|---|---|
|
| |||
| 0-14 | 4 | 3 (1.4) | - |
| 15-30 | 244 | 86(40.9) | 0.043 |
| 31-45 | 170 | 80(38.1) | 0.030 |
| 46-59 | 83 | 35(16.6) | 0.762 |
| >60 | 23 | 6(2.8) | 0.236 |
|
| 0.583 | ||
| Male | 366 | 150(71.4) | |
| Female | 158 | 60(28.6) | |
|
| 0.079 | ||
| Pulmonary (Smear positive) | 389 | 165(78.6) | |
| Extra pulmonary or pulmonary smear negative | 135 | 45(21.4) | |
|
| 0.076 | ||
| PAN susceptible[ | 418 | 176(83.8) | |
| Drug resistant | 10 | 34(16.2) | |
|
| |||
| Saudi | 210 | 68(32.4) | 0.004 |
| South Asia | 185 | 77(36.6) | 0.659 |
| South East Asia | 96 | 50(23.8) | 0.011 |
| West Asia | 17 | 8(3.8) | 0.729 |
| Africa | 16 | 7(3.3) | 0.963 |
Susceptible to all the first line drugs tested.